1991 Dodge Ram W-250 Cummins Turbo Diesel 4x4 Regular Cab on 2040-cars

Auto blog

2014 Dodge Journey Crossroad

Watchers of the auto industry will notice a theme among the formerly bankrupted American automakers, General Motors and Chrysler. There are the post-bankruptcy vehicles, and the pre-bankruptcy vehicles. The former, in the case of Chrysler, include the Jeep Grand Cherokee, as well as the 200 and 300. For GM, there's the Cadillac ATS, Chevrolet Impala and Buick Encore, among others. These vehicles have the freshest styling, with sharp exteriors and well-crafted interiors, as well as advanced powertrains and well-sorted chassis.
As for the pre-bankruptcy vehicles, they tend to be easy to spot. Most suffer from inferior driving dynamics, cheaper interiors, poorer fuel economy and often homely looks (we know, there were some decent cars before the bankruptcy, but they were pretty heavily outweighed by the bad ones). Think late, last-generation Chevrolet Impala or Chrysler 200. Increasingly, though, we're seeing vehicles that split the balance between pre- and post-bankruptcy. Vehicles like the Dodge Journey.
The Journey debuted in 2007 as a 2008 model year vehicle, meaning it should fall into the latter category. But heavily breathed upon in 2011, it now enjoys a new, 3.6-liter Pentastar V6, a big, critically acclaimed touchscreen display and in the case of today's tester, a new-for-2014 Crossroad spec.

Dodge Challenger returns to Trans Am

NASCAR's Nationwide Series may have switched (in appearance anyway) to muscle cars, but American racing fans know that if they want to see real muscle cars on the street circuits, the only place to look is Trans Am. The all-American racing series is packed with Mustangs, Camaros and even Corvettes. The one thing it's been missing is the Dodge Challenger, but now SRT Motorsports has announced it's bringing its muscle car back where it belongs.
Rather than waiting until next year, the Miller Racing team is switching mid-season to the new Dodge Challenger SRT Trans Am racer you see here, just in time for this weekend's race at Mid-Ohio. And not just that - it's lined up a compelling pair of drivers to pilot it, as well.
The No. 11 car will be driven by Trans Am legend Tommy Kendall, a four-time series champion who's been off the grid since 2004. Backing him up in the No. 1 Challenger will be none other than Cameron Lawrence, the driver who has won five out of six races in the Chevy Camaro so far this season, losing out only once to American racing scion Adam Andretti.

NHTSA investigating power modules on Chrysler Group SUVs and minivans

The Center for Auto Safety is officially petitioning the National Highway Traffic Safety Administration to begin scrutinizing alleged problems with the totally integrated power module (TIPM) on about 24 Chrysler Group SUVs and minivans. The advocacy group claims that the part's failure can cause affected vehicles to stall or not start at all. NHTSA is still looking into the accusations and deciding whether a full investigation is actually warranted.
The CAS petition claims at least 70 TIPM failures, but according to NHTSA, six of the complaints are for models that don't have the modules. In 34 of the reported cases, the vehicles refused to start, and in 17 of them the engine stalled. There were also two allegations of smoke and one of a fire. However, none of these affected airbag deployment or resulted in a crash.
This petition isn't the first TIPM-related problem for Chrysler Group. A recent report in the New York Times alleged that it found 240 complaints potentially related to the issue on NHTSA's website alone. In September, the automaker also recalled 230,760 examples worldwide (188,723 in the US) of the 2011 Jeep Grand Cherokee and Dodge Durango replace the fuel pump relay circuit inside of the TIPM-7 with one external to the unit. The original part could allegedly cause the models to stall without warning. Even earlier, the company also recalled about 80,000 examples of the Jeep Wrangler and Dodge Nitro in 2007 to have the module reprogrammed.